HealthInvest Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.1M | Sell |
86,933
-2,294
| -3% | -$426K | 6.91% | 2 |
|
|
2025
Q1 | $18.7M | Sell |
89,227
-1,496
| -2% | -$313K | 8.25% | 2 |
|
|
2024
Q4 | $16M | Buy |
90,723
+46,237
| +104% | +$8.15M | 7.58% | 3 |
|
|
2024
Q3 | $8.79M | Buy |
44,486
+8,868
| +25% | +$1.75M | 4.13% | 7 |
|
|
2024
Q2 | $6.11M | Buy |
35,618
+6,272
| +21% | +$1.08M | 3.73% | 11 |
|
|
2024
Q1 | $5.34M | Buy |
29,346
+8,150
| +38% | +$1.48M | 3.25% | 9 |
|
|
2023
Q4 | $3.28M | Buy |
+21,196
| New | +$3.28M | 2.57% | 19 |
|
|
2022
Q4 | $131K | Buy |
+811
| New | +$131K | 0.25% | 12 |
|
|
2022
Q1 | – | Sell |
-48,000
| Closed | -$6.5M | – | 13 |
|
|
2021
Q4 | $6.5M | Buy |
48,000
+33,000
| +220% | +$4.47M | 9.16% | 4 |
|
|
2021
Q3 | $1.62M | Sell |
15,000
-70,000
| -82% | -$7.55M | 2.42% | 13 |
|
|
2021
Q2 | $9.57M | Buy |
85,000
+16,000
| +23% | +$1.8M | 9.07% | 9 |
|
|
2021
Q1 | $7.47M | Sell |
69,000
-18,000
| -21% | -$1.95M | 5.95% | 8 |
|
|
2020
Q4 | $9.32M | Buy |
+87,000
| New | +$9.32M | 6.17% | 8 |
|